Jacqualyn A. Fouse

Chief Executive Officer at Agios Pharmaceuticals, Inc.

Jacqualyn A. Fouse

Jacqualyn A. Fouse

Chief Executive Officer at Agios Pharmaceuticals, Inc.

Overview
Career Highlights

Bunge Ltd.
Swissair Group
Swissai

RelSci Relationships

2184

Number of Boards

13

Birthday

1962

Age

58

Relationships
RelSci Relationships are individuals Jacqualyn A. Fouse likely has professional access to. A relationship does not necessarily indicate a personal connection.

General Partner at GV Management Co. LLC

Relationship likelihood: Strong

Former Executive Vice President & Chief Financial Officer at Biogen, Inc.

Relationship likelihood: Strong

Founder at Agios Pharmaceuticals, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Memorial Sloan-Kettering Cancer Center

Relationship likelihood: Strong

Founder at Agios Pharmaceuticals, Inc.

Relationship likelihood: Strong

Founder at Agios Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Dick's Sporting Goods, Inc.

Relationship likelihood: Strong

Former President, Chief Operating Officer at Dick's Sporting Goods, Inc.

Relationship likelihood: Strong

Chief Legal Officer at Agios Pharmaceuticals, Inc.

Relationship likelihood: Strong

Senior Advisor at The Boston Consulting Group, Inc.

Relationship likelihood: Strong

Paths to Jacqualyn A. Fouse
Potential Connections via
Relationship Science
You
Jacqualyn A. Fouse
Chief Executive Officer at Agios Pharmaceuticals, Inc.
Education
PhD in Finance

The University of Texas at Arlington is a growing research powerhouse committed to life-enhancing discovery, innovative instruction, and caring community engagement. An educational leader in the heart of the thriving North Texas region, UT Arlington nurtures minds within an environment that values excellence, ingenuity, and diversity. Guided by world-class faculty members, the University’s 33,300 students represent 120 countries and pursue more than 180 bachelor’s, master’s, and doctoral degrees in a broad range of disciplines. UT Arlington is dedicated to producing the lifelong learners and critical thinkers our region and nation demand. More than 107,000 of the University’s 169,000 alumni live in North Texas and contribute to our annual economic impact of $12.8 billion in the region. With a growing number of campus residents, UT Arlington has become a first-choice university for students seeking a vibrant college experience. In addition to receiving a first-rate education, our students participate in a robust slate of co-curricular activities that prepare them to become the next generation of leaders.

Boards & Committees
Member, Board of Directors
2017 - Current

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Member, Board of Directors
2017 - Current

Incyte's vision is to become a leading drug discovery, development and commercial company by building a proprietary product pipeline of novel small molecule drugs for serious unmet medical needs. We have experienced management, discovery, clinical development and commercial teams. Our assets, experience and prior success in bringing important new drugs to market put us in a strong position to make a difference in health care, improve the lives of patients and build sustainable value for our shareholders. Our pipeline is focused on oncology and inflammation and includes compounds in various stages of development. Our lead product, Jakafi® (ruxolitinib), a JAK1 and JAK2 inhibitor, is currently approved in the United States for the treatment of intermediate or high-risk myelofibrosis (please see Full Prescribing Information and Important Safety Information for Jakafi) and is in development as a potential treatment for other cancers. We have established multiple collaborations with major pharmaceutical companies to support the clinical development and global commercialization of several of our compounds. Through strategic collaborations with Novartis and Eli Lilly, we are advancing the global development of two of our JAK1 and JAK2 inhibitor programs. Incyte's corporate headquarters is located in Wilmington, Delaware

Member, Board of Directors
2012 - 2016

Based in Allegan, Michigan, U.S.A., Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, active pharmaceutical ingredients (API) and pharmaceutical and medical diagnostic products. The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. At Perrigo, our mission is clear - to provide quality, affordable, healthcare products. An essential part of that mission, of course, is quality. "Quality" is more than a concept at Perrigo, it is our most important priority. That is why we continually invest our time and resources in the quest to achieve ever higher levels of quality execution and quality products - for you, our own family members and everyone who uses our products

Member, Development Board
Current

The University of Texas at Arlington is a growing research powerhouse committed to life-enhancing discovery, innovative instruction, and caring community engagement. An educational leader in the heart of the thriving North Texas region, UT Arlington nurtures minds within an environment that values excellence, ingenuity, and diversity. Guided by world-class faculty members, the University’s 33,300 students represent 120 countries and pursue more than 180 bachelor’s, master’s, and doctoral degrees in a broad range of disciplines. UT Arlington is dedicated to producing the lifelong learners and critical thinkers our region and nation demand. More than 107,000 of the University’s 169,000 alumni live in North Texas and contribute to our annual economic impact of $12.8 billion in the region. With a growing number of campus residents, UT Arlington has become a first-choice university for students seeking a vibrant college experience. In addition to receiving a first-rate education, our students participate in a robust slate of co-curricular activities that prepare them to become the next generation of leaders.

Member, Board of Directors
Prior

ORBIS International, Inc. prevents and treats blindness by providing eye care to transform lives. It offers tools, training and technology necessary for local partners to develop eye care services. The company was founded in 1982 by David Paton and is headquartered in New York, NY.

Member, Advisory Board
Prior

The Neeley School is one of the oldest in Texas. TCU was founded in 1873 by brothers Addison and Randolph Clark in Thorp Spring, Texas, as AddRan Male and Female College, and the School of Business opened in 1884 as Commercial School, renamed School of Business in 1896, and College of Business in 1901. The Department of Business Administration was established in 1922, and became the School of Business in 1938, the first year to offer a master of business administration. Student organizations included the TCU Chamber of Commerce, begun in 1939, and the Collegiate Business and Professional Women’s Club. E. M. Sowell was appointed the first dean in 1944. In 1967, the School of Business was named for M.J. Neeley in honor of his personal service of 25 years on the TCU Board of Trustees and financial contributions to TCU. Applications have risen steadily in recent years. The Neeley School of Business currently makes up one-third of the TCU student population. The Neeley School of Business is the undergraduate and graduate business school at Texas Christian University (TCU), a private university located in Fort Worth, Texas. The Neeley School is fully accredited by the AACSB; Neeley’s Accounting program is among approximately 200 schools worldwide to be accredited by AACSB.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1,000 - $4,999
2017

Sinai Health System now consists of Mount Sinai Hospital, Holy Cross Hospital, Sinai Children’s Hospital, Schwab Rehabilitation Hospital, Sinai Medical Group, Sinai Community Institute and Sinai Urban Health Institute. Mount Sinai Hospital is a 319-bed teaching, research and tertiary-care facility that provides medical, surgical, behavioral health, therapeutic and diagnostic services to Chicago's West Side, as well as to others in the metropolitan area requiring sophisticated medical and surgical care. The Emergency Department is one of four Level I trauma centers in Chicago, treating both adult and pediatric trauma patients. Holy Cross Hospital, a 274-licensed bed community hospital, provides medical, surgical, intensive, emergency, labor and delivery, rehabilitation, outpatient and primary care services as well as a Seasons Hospice and Palliative Care unit. Its Emergency Department delivers comprehensive care for a broad range of critical and urgent medical needs. Holy Cross Hospital has achieved the Health Facilities Accreditation Program Primary Stroke Center certification. Holy Cross Hospital works closely with area churches, schools, institutions and organizations to build strong, safe and healthy communities. Sponsored by the Sisters of St. Casimir in 1928, Holy Cross Hospital follows the United States Conference of Catholic Bishops Ethical and Religious Directives for Catholic Healthcare.

$1,000 - $4,999
2016

Sinai Health System now consists of Mount Sinai Hospital, Holy Cross Hospital, Sinai Children’s Hospital, Schwab Rehabilitation Hospital, Sinai Medical Group, Sinai Community Institute and Sinai Urban Health Institute. Mount Sinai Hospital is a 319-bed teaching, research and tertiary-care facility that provides medical, surgical, behavioral health, therapeutic and diagnostic services to Chicago's West Side, as well as to others in the metropolitan area requiring sophisticated medical and surgical care. The Emergency Department is one of four Level I trauma centers in Chicago, treating both adult and pediatric trauma patients. Holy Cross Hospital, a 274-licensed bed community hospital, provides medical, surgical, intensive, emergency, labor and delivery, rehabilitation, outpatient and primary care services as well as a Seasons Hospice and Palliative Care unit. Its Emergency Department delivers comprehensive care for a broad range of critical and urgent medical needs. Holy Cross Hospital has achieved the Health Facilities Accreditation Program Primary Stroke Center certification. Holy Cross Hospital works closely with area churches, schools, institutions and organizations to build strong, safe and healthy communities. Sponsored by the Sisters of St. Casimir in 1928, Holy Cross Hospital follows the United States Conference of Catholic Bishops Ethical and Religious Directives for Catholic Healthcare.

$2,500 - $4,999
2013

Pancreatic Cancer Action Network, Inc. engages in the research, clinical initiatives, patient services, and advocacy for pancreatic cancer. The company was founded in 1999 and is headquartered in Manhattan Beach, CA.

Political Donations
$1,000
2012

Former Republican Budget Officer at New Jersey State Senate

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jacqualyn A. Fouse. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jacqualyn A. Fouse's profile does not indicate a business or promotional relationship of any kind between RelSci and Jacqualyn A. Fouse.